MALAT1 and nasopharyngeal carcinoma: Other recent studies have reported that miR-9, miR-101 and miR-217 target MALAT1 for degradation in other human cancer cell lines.49, 50 This evidence also supports our finding that miR-25 downregulates MALAT1 expression in NPC.